1. Panayotopoulou EG, Sgouras DN, Papadakos KS, Petraki K, Breurec S, Michopoulos S, et al. CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer disease. J Clin Microbiol. 2010;48(6):2237–9.
2. Beltrán F, Poblete T, Román A, Reyes S, Sampedro J, Peralta O, et al. The EPIYA-ABCC motif pattern in CagA of Helicobacter pyloriis associated with peptic ulcer and gastric cancer in Mexican population. BMC Gastroenterol [Internet]. 2014;14(1):223. Available from: http://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-014-0223-9
3. Cavanna L, Pagani R, Seghini P, Zangrandi A, Paties C. High grade B-cell gastric lymphoma with complete pathologic remission after eradication of helicobacter pylori infection: Report of a case and review of the literature. World J Surg Oncol. 2008;6:1–7.
4. Zhang XY, Zhang PY, Aboul-Soud MAM. From inflammation to gastric cancer: Role of Helicobacter pylori. Oncol Lett. 2017;13(2):543–8.
5. Adamu MA, Weck MN, Gao L, Brenner H. Incidence of chronic atrophic gastritis : systematic review and meta-analysis of follow-up studies. Eur J Epidemiol. 2010;25(7):439–48.
6. Cover TL, Blanke SR. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol. 2005;3(4):320–32.
7. Zhu P, Xue J, Zhang ZJ, Jia YP, Tong YN, Han D, et al. Helicobacter pylori VacA induces autophagic cell death in gastric epithelial cells via the endoplasmic reticulum stress pathway article. Cell Death Dis [Internet]. 2017;8(12). Available from: http://dx.doi.org/10.1038/s41419-017-0011-x
8. Yahiro K, Akazawa Y, Nakano M, Suzuki H, Hisatune J, Isomoto H, et al. Helicobacter pylori VacA induces apoptosis by accumulation of connexin 43 in autophagic vesicles via a Rac1/ERK-dependent pathway. Cell Death Discov [Internet]. 2015;1:15035.
9. Sgouras DN, Panayotopoulou EG, Papadakos K, Martinez-Gonzalez B, Roumbani A, Panayiotou J, et al. CagA and VacA polymorphisms do not correlate with severity of histopathological lesions in Helicobacter pylori-infected Greek children. J Clin Microbiol. 2009;47(8):2426–34.
10. Sgouras D, Trang TTH, Yamaoka Y. Pathogenesis of Helicobacter pylori infection. Helicobacter . 2015;20:8–16.
11. Miehlke S, Kirsch C, Agha-Amiri K, Günther T, Lehn N, Malfertheiner P, et al. The Helicobacter Pylori vacA s1 , m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer. 2000;87:322–7.
12. Panayotopoulou EG, Sgouras DN, Papadakos K, Kalliaropoulos A, Papatheodoridis G, Mentis AF, et al. Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates. J Clin Microbiol. 2007;45(2):488–95.
13. Jones KR, Joo YM, Jang S, Yoo YJ, Lee HS, Chung IS, et al. Polymorphism in the cagA EPIYA motif impacts development of gastric cancer. J Clin Microbiol. 2009;47(4):959–68.
14. Neel BG, Gu H, Pao L. The ’Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci. 2003;28(6):284–93.
15. Nagase L, Hayashi T, Senda T, Hatakeyama M. Dramatic increase in SHP2 binding activity of Helicobacter pylori Western CagA by EPIYA-C duplication: Its implications in gastric carcinogenesis. Sci Rep. 2015;5:1–13.
16. Basso D, Zambon C-F, Letley DP, Stranges A, Marchet A, Rhead JL, et al. Clinical Relevance of Helicobacter pylori cagA and vacA Gene Polymorphisms. Gastroenterology. 2008;135:91–9.
17. Li Q, Liu J, Gong Y, Yuan Y. Association of CagA EPIYA-D or EPIYA-C phosphorylation sites with peptic ulcer and gastric cancer risks. Medicine. 2017;96(17).
18. Bridge DR, Blum FC, Jang S, Kim J, Cha JH, Merrell DS. Creation and Initial Characterization of Isogenic Helicobacter pylori CagA EPIYA Variants Reveals Differential Activation of Host Cell Signaling Pathways. Sci Rep. 2017;7(1):1–14.
19. International Agency for Research on Cancer. Infection with Helicobacter pylori. Vol. 61, Monographs on the evaluation of carcinogenic risks to humans. Lyon, France; 1994. 177–240.
20. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol. 1996;20:1161–81.
21. Smith SI, Oyedeji KS, Arigbabu AO, Cantet F, Megraud F, Ojo OO, et al. Comparison of three PCR methods for detection of Helicobacter pylori DNA and detection of cag A gene in gastric biopsy specimens. World J Gastroenterol. 2004;10(13):1958–60.
22. Madhi M, Poursina F, Moghim S, Khademi F, Adibi P, Faghr J, et al. Recommendation of flaA and flaB as housekeeping genes in detection of Helicobacter pylori. J Chem Biol Phys Sci. 2013;3(4):2687–96.
23. Oktem-okullu S, Tiftikci A, Saruc M, Cicek B, Vardareli E, Tozan N, et al. Multiplex-PCR-Based Screening and Computational Modeling of Virulence Factors and T-Cell Mediated Immunity in Helicobacter pylori Infections for Accurate Clinical Diagnosis. PLoS One. 2015;17:1–13.
24. Torres L, González L, Melián K, Alonso J, Moreno A, Hernández M, et al. EPIYA motif patterns among Cuban Helicobacter pylori CagA positive strains. Biomedica. 2012;32:23–31.
25. Kusters J, Van Vliet A, Kuipers E. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev. 2006;19(3):449–90.
26. Atrisco J, Martínez V, Román A, Alarcón J, Sampedro J, Cruz I, et al. vacA s1m1 genotype and cagA EPIYA-ABC pattern are predominant among Helicobacter pylori strains isolated from Mexican patients with chronic gastritis. J Med Microbiol. 2018;67:314–24.
27. Reyes J, Guzmán K, Morales E, Villacís J, Pazmiño G, Pacheco R, et al. Susceptibilidad antibiótica de Helicobacter pylori : un estudio de prevalencia en pacientes con dispepsia en. Rev Colomb Gastroenterol. 2017;32(4):6–10.
28. Porras C, Nodora J, Sexton R, Ferreccio C. Epidemiology of Helicobacter pylori infection in six Latin American countries ( SWOG Trial S0701 ). Springer Sci. 2013;209–15.
29. Burucoa C, Axon A. Epidemiology of Helicobacter pylori infection. Helicobacter. 2016;21:3–7.
30. De Vries AC, Van Grieken NC, Looman CW, Casparie MK, De Vries E, Meijer GA, et al. Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands. Gastroenterology. 2008;134:945–52.
31. Annibale B, Negrini R, Caruana P, Lahner E, Grossi C, Bordi C, et al. Two-thirds of Atrophic Body Gastritis Patients Have Evidence of Helicobacter pylori Infection. Helicobacter. 2001;6(3):225–33.
32. Vilar A, Ribeiro M, Maria R, Ferreira D, Santos KN, Aparecida R, et al. Evaluation of the Pattern of EPIYA Motifs in the Helicobacter pylori cagA Gene of Patients with Gastritis and Gastric Adenocarcinoma from the Brazilian Amazon Region. Int J Bacteriol. 2014;
33. Myint T, Shiota S, Vilaichone RK, Ni N, Aye TT, Matsuda M, et al. Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar. World J Gastroenterol. 2015;21(2):612–9.
34. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer. 2004;109(1):138–43.
35. Djekic A, Müller A. The Immunomodulator VacA Promotes Immune Tolerance and Persistent Helicobacter pylori Infection through Its Activities on T-Cells and Antigen-Presenting Cells. Toxins. 2016;8(187):1–9.
36. Winter JA, Letley DP, Cook KW, Rhead JL, Zaitoun AAM, Ingram RJM, et al. A Role for the Vacuolating Cytotoxin , VacA , in Colonization and Helicobacter pylori – Induced Metaplasia in the Stomach. J Infect Dis. 2014;210:954–63.
37. Trang TTH, Binh TT, Yamaoka Y. Relationship between vacA types and development of gastroduodenal diseases. Toxins. 2016;8(6):12–4.
38. Memon AA, Hussein NR, Miendje Deyi VY, Burette A, Atherton JC. Vacuolating cytotoxin genotypes are strong markers of gastric cancer and duodenal ulcer-associated Helicobacter pylori strains: A matched case-control study. J Clin Microbiol. 2014;52(8):2984–9.
39. Jang S, Jones KR, Olsen CH, Joo YM, Yoo Y-J, Chung I-S, et al. Epidemiological Link between Gastric Disease and Polymorphisms in VacA and CagA. J Clin Microbiol. 2010;48:559–67.
40. Atherton J, Cao P, Peek R, Tummuru JM, Blaser M, Cover T. Mosaicismo in Vacuolating Cytotoxin Alleles of Helicobacter pylori. J Biol Chemestry. 1995;270(30):17771–7.
41. Yamaoka Y, EL-Zimaity HM., Gutierrez O, Figura N, Kim J., Kodama T, et al. Relationship Between the cagA 3´ Repeat Region of Helicobacter pylori, Gastric Histology, and Susceptibility to Low pH. Gastroenterology. 1999;117(2):342–9.
42. Gao L, Weck MN, Michel A, Pawlita M, Brenner H. Association between Chronic Atrophic Gastritis and Serum Antibodies to 15 Helicobacter pylori Proteins Measured by Multiplex Serology. Cancer Res. 2009;69(7):2973–81.
43. Yamaoka Y, Graham D. Helicobacter pylori virulence and cancer pathogenesis. Futur Oncol. 2014;10:1487–500.
44. Backert S, Tegtmeyer N, Selbach M. The Versatility of Helicobacter pylori CagA Effector Protein Functions : The Master Key Hypothesis. Helicobacter. 2010;15(3):163–76.
45. Nešic D, Buti L, Lu X, Stebbins CE. Structure of the Helicobacter pylori CagA oncoprotein bound to the human tumor suppressor ASPP2. Proc Natl Acad Sci. 2014;111(4):1562–7.
46. Vaziri F, Peerayeh SN, Alebouyeh M, Maghsoudi N, Azimzadeh P, Siadat SD, et al. Novel effects of Helicobacter pylori CagA on key genes of gastric cancer signal transduction : a comparative transfection study. FEMS Pathog Dis. 2015;73(3):1–8.
47. Hatakeyama M. Anthropological and clinical implications for the structural diversity of the Helicobacter pylori. Clin J Japanese Cancer Asoc. 2010;102(1):36–43.
48. Zhang X, Tegtmeyer N, Traube L, Jindal S, Perez- G, Sticht H, et al. A Specific A / T Polymorphism in Western Tyrosine Phosphorylation B-Motifs Regulates Helicobacter pylori CagA Epithelial Cell Interactions. PLOS Pathog. 2015;11(2):1–26.
49. Karlsson A, Ryberg A, Nosouhi Dehnoei M, Borch K, Monstein H-J. Variation in number of cagA EPIYA-C phosphorylation motifs between cultured Helicobacter pylori and biopsy strain DNA. Infect Genet Evol. 2011;175–9.